Results 1 to 10 of about 4,204,532 (240)

Locally advanced breast cancer [PDF]

open access: yesBreast, 2022
Locally advanced breast cancer (LABC) is defined here as inoperable breast adenocarcinoma without distant metastases. Patients with LABC require a multidisciplinary approach. Given the risk of distant metastasis, staging exams are necessary.
Stefan Aebi   +2 more
doaj   +3 more sources

The health system and access to treatment in patients with cervical cancer in Mexico

open access: yesFrontiers in Oncology, 2022
Cervical cancer (CC) is tightly related to a low Human Development Index. Mexico is an upper-middle-income country with 126 million inhabitants, and its public health system aims to provide universal health coverage.
Eder A. Arango-Bravo   +14 more
doaj   +1 more source

PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer.

open access: yesNew England Journal of Medicine, 2022
BACKGROUND Neoadjuvant chemotherapy and radiation followed by surgical resection of the rectum is a standard treatment for locally advanced rectal cancer. A subset of rectal cancer is caused by a deficiency in mismatch repair.
A. Cercek   +31 more
semanticscholar   +1 more source

Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial.

open access: yesThe Lancet Oncology, 2021
BACKGROUND Treatment of locally advanced rectal cancer with chemoradiotherapy, surgery, and adjuvant chemotherapy controls local disease, but distant metastases remain common.
T. Conroy   +22 more
semanticscholar   +1 more source

Neoadjuvant Systemic Therapy for Locally Advanced Breast Cancer in St. Luke’s Medical Center: 10-Year Local Experience and Response Rates

open access: yesAsian Pacific Journal of Cancer Care, 2023
Background: Neoadjuvant therapy has given important prognostic and predictive information based on pathologic response as seen on studies showing that pathologic complete response (pCR) is associated with favorable disease-free and overall survival in ...
Mel Valerie B. Cruz-Ordinario   +4 more
doaj   +1 more source

Multicenter, Randomized, Phase III Trial of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy in Locally Advanced Rectal Cancer (STELLAR)

open access: yesJournal of Clinical Oncology, 2022
PURPOSE To ascertain if preoperative short-term radiotherapy followed by chemotherapy is not inferior to a standard schedule of long-term chemoradiotherapy in patients with locally advanced rectal cancer.
Jing Jin   +34 more
semanticscholar   +1 more source

Real World Data of Response of Trastuzumab Based Chemotherapy in Locally Advanced HER2 Positive Breast Cancer from a Developing Country

open access: yesAsian Pacific Journal of Cancer Care, 2021
Background: Data regarding pathologic response of Trastuzumab based chemotherapy in locally advanced HER2 positive breast cancer in neoadjuvant setting is scarce.
Dinesh Chandra Doval   +8 more
doaj   +1 more source

A Retrospective Evaluation of Clinical Profile of Second Primary Head and Neck Cancer [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2016
Introduction: Incidence of Second Primary Malignancy (SPM) after successful treatment of primary is increasing and may cause the problem for optimal treatment.
Paramjeet Kaur   +4 more
doaj   +1 more source

Patterns of failure in locally advanced female breast carcinoma treated with neoadjuvant chemotherapy followed by surgery and radiotherapy – A prospective study

open access: yesAsian Journal of Medical Sciences, 2023
Background: The use of combined modality therapy including surgery, chemotherapy, and radiotherapy increases five survival rates in stage IIA and stage IIIB disease to 80% and 45%, respectively. Neoadjuvant chemotherapy (NACT) eradicates micro metastasis
Shilpi Adhikary   +5 more
doaj   +1 more source

Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world study

open access: yesCell Reports Medicine, 2023
Summary Predicting the clinical response to chemotherapeutic or targeted treatment in patients with locally advanced or metastatic lung cancer requires an accurate and affordable tool.
Han-Min Wang   +19 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy